Loading organizations...
Key people at cGMP Validation.
cGMP Validation LLC is a Kansas City, Missouri-based consulting firm that provides full-service regulatory validation and compliance solutions for equipment, utilities, manufacturing processes, laboratory instruments, and computer systems. Structured as a fee-for-service business, the company specializes in preparing and executing IQ/OQ/PQ protocols, facility commissioning, regulatory auditing, risk assessment, and educational training programs. The organization supports clients operating within highly regulated industries, including the pharmaceutical, animal health, biotechnology, biologics, medical device, and medical diagnostic sectors. Operating with approximately 88 employees across multiple satellite offices, the firm generates an estimated $7.6 million in annual revenue and has completed over 300 successful compliance projects. Led by executives including Jesse Gillikin and Phil Murray, the company serves international markets such as Canada, Egypt, Germany, and Italy. cGMP Validation LLC was established in 1997 by currently undisclosed founders.
Key people at cGMP Validation.
cGMP Validation LLC is a full-service validation and compliance firm founded in 1997, specializing in ensuring regulatory adherence for pharmaceutical, biotechnology, medical device, and related industries.[1][2][3][6] It provides expertise in areas like facility commissioning, equipment qualification, cleaning validation, computer validation, GMP auditing, and training, serving clients from small startups to large manufacturers across North America and internationally with a team of 88-94 professionals skilled in chemistry, microbiology, engineering, pharmacy, and computer science.[1][2][3] The company reports annual revenue between $7.6 million and $22.9 million, has received $350,000 in funding, and emphasizes project management to deliver on-time, on-budget services tailored to FDA expectations and industry standards.[1][4]
Its growth momentum stems from a seasoned team—many former QA managers, production leads, and facility managers—enabling seamless coordination on complex projects like process validation, aseptic processing, and compliance programs, positioning it as a reliable partner in highly regulated life sciences sectors.[1][2][6]
cGMP Validation LLC was established in 1997 in the Kansas City area (with offices in Shawnee, Kansas, and Kansas City, Missouri) to address validation and compliance needs in the expanding pharmaceutical and biotech industries.[1][3] While specific founders are not detailed in available records, Jesse Gillikin, with pharmaceutical experience since 1978 in validation, QC labs, auditing, and FDA interactions, leads as President and CEO, overseeing all operations and leveraging his expertise in non-sterile/sterile products, cleaning, and computer validation.[1][4][6]
Key leaders include Laura Gillikin (VP since 1986, expert in microbiology, QA, vaccine production, and aseptic processing), Christopher Gillikin (COO and Owner), and Phil Murray (Director of Computer Validation since 2001, managing GxP computerized systems).[4][6] Early traction came from building a team of industry veterans, securing projects with diverse clients, and expanding internationally, evolving from core validation services to comprehensive compliance solutions amid rising FDA scrutiny.[1][2]
cGMP Validation rides the wave of stringent global regulations in life sciences, where cGMP (current Good Manufacturing Practices) and FDA oversight demand rigorous validation to prevent contamination, ensure product safety, and accelerate approvals amid booming biotech and pharma innovation.[1][2] Timing is ideal as personalized medicine, biologics, and medtech surge—market forces like supply chain complexities post-pandemic and rising biosimilar competition amplify needs for compliant startups and scale-ups.[3][4]
The firm influences the ecosystem by enabling faster market entry for clients through expert validation, reducing audit risks, and supporting tech integrations like computerized systems in GxP environments, indirectly fueling growth in a $1.5+ trillion global pharma market.[1][6]
cGMP Validation is poised for steady expansion by capitalizing on digital transformation in pharma—think AI-driven processes and advanced therapeutics requiring next-gen validation—while its experienced team navigates evolving FDA guidelines on data integrity and real-world evidence.[1][6] Trends like decentralized manufacturing and ESG-focused compliance will shape its trajectory, potentially boosting revenue through partnerships with emerging cell/gene therapy firms. Its influence may grow via talent development and service innovation, solidifying its role as a compliance cornerstone in a compliance-first biotech boom, much like its 25+ years of bridging operational expertise with regulatory demands.[2][4]
